CHNA vs PCI

Loncar China BioPharma ETF

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.

PIMCO Dynamic Credit and Mortgage Income Fund

PIMCO Dynamic Credit and Mortgage Income Fund is a closed end fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in fixed income markets across the globe. The fund utilizes a dynamic asset allocation approach and seeks to invest in multiple fixed-income sectors in the global credit markets, including corporate debt, mortgage-related and other asset-backed securities, government and sovereign debt, taxable municipal bonds and other fixed, variable and floating rate income producing securities. It benchmarks the performance of its portfolio against a combined benchmark comprised of 80% Barclays Investment Grade Index and 20% BofA High Yield Index. The fund was formerly known as PIMCO Dynamic Credit Income Fund. PIMCO Dynamic Credit and Mortgage Income Fund was formed on January 31, 2013 and is domiciled in the United States.